If you're in the Triangle area and curious about the human microbiome, the science behind taste, or how benign parasites might impact medicine, join us at @fuqua.duke.edu on March 20 at 12:45 in the Kirby Reading Room for a talk by Rob Dunn, biologist and author of "Delicious" and other books.
17.03.2025 18:24 — 👍 4 🔁 1 💬 1 📌 0
If a drugmaker increases its commercial price over time, it must pay a rebate to the US government. This somewhat dampens price increases and lowers the net price paid by the government. But what if the drugmaker resets its price by launching a new version? @warren.senate.gov wants an investigation.
12.03.2025 22:13 — 👍 1 🔁 0 💬 0 📌 0
YouTube video by Duke University School of Medicine
Dr. Shelley Hwang - Surgical Oncologist, Mountain Climber
Less is often more, according to Shelley Hwang, MD, MBA, of @DukeU. In @JAMA_current, she and coauthors demonstrated that monitoring is a safe, less invasive approach for low-risk ductal carcinoma in situ (DCIS).
Video: youtu.be/_fuC8cFlsXU
Article: jamanetwork.com/journals/jam...
13.01.2025 16:59 — 👍 3 🔁 0 💬 0 📌 0
Novel Drug Approvals for 2024
Novel Drug Approvals for 2024
The @US_FDA published a great summary of novel drug approvals in 2024 here:
www.fda.gov/drugs/novel-...
11.01.2025 13:20 — 👍 0 🔁 0 💬 0 📌 0
In 2024, @US_FDA approved 50 novel drugs, including:
• 34 first approved in the US
• 26 orphan drugs (<200K Americans affected)
• 7 accelerated approvals (conditional approval on surrogate endpoints)
• 28 priority reviews (6-month FDA review)
Cancer drug Bizengri was all 4.
11.01.2025 13:20 — 👍 0 🔁 0 💬 1 📌 0
The Quarterly Journal of Economics is the oldest professional journal of Economics in the English language. Edited by the Department of Economics at Harvard.
Professor, Washington University in St. Louis
Co-Director Center for Advancing Health Services Policy and Economics Research.
https://source.washu.edu/experts/timothy-mcbride/
Substack: https://timothymcbride.substack.com/
Views my own.
Graduate management education focused on making society better through business. #teamfuqua
Co-founder & editor, Works in Progress. Writer, Scientific Discovery. Podcaster, Hard Drugs. Advisor, Open Philanthropy. // Previously at Our World in Data.
Newsletter: https://scientificdiscovery.dev
Podcast: https://harddrugs.worksinprogress.co
🏳️🌈
Prof at @DukeFuqua, formerly @HarvardHBS @UCBerkeley. Studying how crisis R&D, tech policy, automation affect firms & economies. http://dpgross.com
Health Economist. Associate Professor & Vice Chair for Research and Practice. Director, Center for Mental Health and Addiction Policy. Department of Health Policy and Management. Johns Hopkins University.
Health services researcher at Vanderbilt Health Policy. Avid coffee drinker, investigator of drug policies & prices. RT not an endorsement. Opinions are mine.
Economist. Professor at University of Chicago, Harris Public Policy. I study the economics of healthcare — doctors, nurses, insurance, plus some labor and urban economics. www.gottlieb.ca
APPAM is dedicated to improving public policy and management by fostering excellence in research, analysis, and education.
Off of social media for now
Assistant Professor, Health Services, Policy & Management @ University of South Carolina.
I study individual choice health insurance.
All opinions are mine and mine alone.
professor @dartmouth + science policy @ifp //
leveraging research to promote science and progress
Studying the management of [healthcare] organizations @Berkeley Haas / PhD @Wharton / Undergrad @Swarthmore / Born @Dominican Republic / 👩🏫📚💄🐰🐶/ www.ambarlaforgia.com
Health economist focusing on the healthcare workforce, institute director, live music fan, mother, cat lover, knitter, hiker, skier. All opinions and snark my own.
Health economist. Associate professor at University of Georgia and RA at NBER. www.EmilyCLawler.com
Economist at Questrom School of Business, Boston University. Research Associate at the National Bureau of Economic Research. Co-author of "Better Health Economics: An Introduction for Everyone."
Assistant professor at Northwestern University.
Health economist and policy researcher studying Medicaid, state policy, behavioral health, and telehealth.
Economics from the head and the heart.
Health economist, health services and health policy researcher, long-term care, family caregiving. Department of Population Health Sciences Duke University and Duke-Margolis Institute for Health Policy
Econ prof University of Zurich.
Faculty affiliate at JPAL, CEPR, CESifo.
Board member IIPF, Helvetas, GAIN.
#EconSky
